Cure8 research brief
Identifies features associated with the new international definition of difficult‑to‑treat Crohn’s disease and links DTT status to greater mental fatigue. Biomarker differences (IL‑5, IL‑10) may point to distinct immune profiles that could matter for research and personalized care.
Adult Crohn’s disease patients (especially those with complex perianal disease or fatigue), gastroenterology clinicians, and researchers studying IBD phenotypes, fatigue, or immune biomarkers.
The article reports that about half of the 175 patients met at least one DTT‑CD criterion, with complex perianal disease being the most common feature. Longer disease duration, higher IL‑5 and IL‑10 levels, higher hemoglobin, and need for partial enteral nutrition were identified as independent risk factors for DTT‑CD in this cohort.
The paper also found that patients who met DTT‑CD criteria had higher mental fatigue scores, and within the DTT group fatigue was associated with partial enteral nutrition, diagnosis after age 40, and prior surgery.
The authors suggest an immunophenotype signal (elevated IL‑5 and IL‑10) in these patients, but this is observational and from a single-center retrospective sample.
Single‑center, retrospective design and modest sample size limit generalizability. The extracted content is the article abstract; findings should be interpreted as associations that require validation in other cohorts and prospective studies.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This article reports an investigational stem cell therapy (StemSmart MSCs) showing safety and clinical responses in a small group of patients with fistulising Crohn’s disease — a serious complication that’s often hard to...
This trial shows darvadstrocel did not outperform placebo for complex perianal Crohn’s fistulas, so it does not support changing care now. High healing rates after surgical curettage and closure suggest the surgical step...
This article reports the start of a first-in-human trial testing extracellular vesicles as a new regenerative treatment for complex perianal fistulas in Crohn's disease, a hard-to-treat complication with limited options.
